Rebound in community antibiotic consumption after the observed decrease during the COVID-19 pandemic, EU/EEA, 2022.
JSON
Ventura-Gabarró C, Leung VH, Vlahović-Palčevski V, Machowska A, Monnet DL, Högberg LD, ESAC-Net study group , ESAC-Net study group participants
Euro Surveill 28 (46) - [2023-11-00; online 2023-11-17]
We observed a rebound in consumption of antibacterials for systemic use (ATC J01) in the community sector in the European Union/European Economic Area during 2021 and 2022, after an observed decrease between 2019 and 2020. The rates in 2022 returned to pre-COVID-19-pandemic levels and were exceeded in 13 countries. Although these patterns could partly be a result of changes in disease transmission during the study period, it could also reflect a lost opportunity to strengthen and reinforce prudent antibiotic use.
PubMed 37971660
DOI 10.2807/1560-7917.ES.2023.28.46.2300604
Crossref 10.2807/1560-7917.ES.2023.28.46.2300604